CBS Evening News, April 15, 2020
Governor orders all New Yorkers to wear face coverings when outdoors; Exercising under quarantine
Watch CBS News
Governor orders all New Yorkers to wear face coverings when outdoors; Exercising under quarantine
A federal judge in Washington said the author of the Constitution "would be aghast" at the NSA's collection of phone records of millions of Americans; and, cockroach farming is big business in China, since pharmaceutical companies use roaches to make products for use in traditional Chinese medicines. Seth Doane goes inside one farm whose owner says he makes $160,000 a year from the bugs.
The National Transportation Safety Board held a hearing about the crash of Flight 214, which killed three people and raised questions about whether pilots have become too reliant on automated systems; and, after just nine months on the job, Pope Francis has rejuvenated a Catholic Church once mired in scandal.
Moderna early data shows coronavirus vaccine is nearly 95% effective; Shelter dog becomes a K-9 officer in New York
U.S. prepares for mass COVID-19 vaccine rollout as FDA weighs authorization; Secret Santa mails Christmas cash to essential workers
FDA panel recommends approval of Pfizer COVID-19 vaccine for emergency use; Andrea Bocelli and daughter starring in online Christmas concert
New York City death toll spikes with revised count; California business owner fights to keep employees on payroll
White House directs staff to wear face masks in the West Wing; Some imported face masks failing to protect first responders from coronavirus
Protests intensify as dozens of states ease restrictions; Kids across America air minor lockdown grievances
Hurricane Laura could make landfall on Gulf Coast as a Category 3 storm; Hospital guard turned medical student strives to help others achieve their dreams
Dr. Scott Gotlieb, the former FDA commissioner, says vaccines and boosters could provide a "backstop" against the latest variant of the coronavirus.
The FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the approval process for Aduhelm has stirred controversy. Correspondent Susan Spencer talks with experts about the clinical benefits of this new class of drugs; and with early-onset Alzheimer's patients, including a former neurologist who enrolled in an early trial of Aduhelm.
Coronavirus cases are rising in more than 30 states ahead of Thanksgiving. It comes as the White House reports about 3 million Americans received a third dose over the weekend following the FDA's authorization of both Moderna and Pfizer's booster for all adults. Vice Dean of Johns Hopkins University's Bloomberg School of Public Health Dr. Joshua Sharfstein joined CBSN's Elaine Quijano to discuss.
Moderna has formally requested the FDA authorize expansion of its COVID-19 booster shot to all adults. Federal health officials are expected to authorize expansion of Pfizer's booster this week. It comes as cases continue to rise across the U.S. Emergency medicine physician Dr. Owais Durrani joins CBSN's Lana Zak to discuss.
The pharmaceutical giant has asked the federal regulators to authorize the experimental pill, called Paxlovid.
The Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine booster shot for all adults in the U.S. as soon as this week. Pfizer is also seeking emergency-use authorization for its COVID antiviral pill. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
The drugmaker filed for emergency use authorization last week.
The drugmaker is asking regulators to authorize its experimental coronavirus pill for people with mild to moderate infections.
Pfizer is requesting FDA authorization of its antiviral COVID-19 pill. The company's study found it is nearly 90% effective in cutting hospitalizations and deaths from the virus. Meanwhile, at least 20 states are experiencing upticks in infections. Infectious disease physician at the University of Michigan Dr. Payal Patel joins CBSN's Elaine Quijano to discuss the latest pandemic news.
The CDC reports over 1 million children ages 5 to 11 have received the first dose of Pfizer's pediatric vaccine. This comes as several states and New York City begin expanding booster eligibility to all adults. Director of vaccine research at Cincinnati Children's Hospital, Dr. Robert Frenck, joins CBSN's Elaine Quijano with a look at the day's pandemic news.
Some suffering from Post-Traumatic Stress Disorder have had little relief from traditional anti-depressants; now, a recent FDA-approved trial using MDMA – a.k.a. ecstasy – has shown promising results.
Califf also served in this role during the Obama administration.
Pfizer is asking the FDA to authorize use of its COVID-19 booster shot for all U.S. adults age 18 and over. Meanwhile, the vaccine rollout of the lower-dose Pfizer vaccine for kids ages 5 to 11 is underway. Dr. Susannah Hills, a pediatric airway surgeon, joined CBSN to discuss the latest coronavirus headlines.
Pfizer has asked the FDA to authorize its COVID-19 vaccine booster shots for Americans 18 and older. As CBS News' Nikki Battiste reports, a third dose has only been authorized for those who are 65 and older or at high risk for the virus. Then, Dr. Angela Myers, director of the infectious diseases division at Children's Mercy Kansas City, joins CBSN's Elaine Quijano to discuss the latest on the pandemic.
Pfizer asked the FDA to authorize booster doses of its COVID-19 vaccine for all adults, ages 18 and older. Right now, it's only authorized for seniors and high-risk adults. Nikki Battiste has the latest.